Director - Drug Delivery Technologies at Eli Lilly and Company

Boston, Massachusetts, United States

Apply Now

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceutical, HealthcareIndustries

Requirements

PhD in Pharmaceutical Sciences, Chemistry, Materials Science, Chemical Engineering, or a related field

Responsibilities

Provide leadership to nanomedicine and targeted delivery application
Provide leadership for the development and implementation of our portfolio in delivery strategies and actively engage functional leaders across organizations to drive strategies that position our teams to deliver the best product to our patients
Drive the creation and execution of strategic project plans to support long range and yearly business plans. Drive external collaborations
In partnership with organizational management, establish, monitor, and evolve functional governances and make recommendations for adjustments as necessary to ensure efficient communication, escalation, and decision making
Leverage the highest quality scientific principles and a drug development mindset to enable strategic and operational objectives
Work with the management team to develop and maintain clear, ongoing communication within and outside of the organization concerning our vision, performance, and impact
Actively contribute to the successful implementation of key initiatives, including acceleration plans, portfolio delivery and sourcing models, and share initiatives and implementation plans
Bring forward proposals and lead implementation of projects from design to delivery that will contribute to successful project delivery as effectively and efficiently as possible
Proactively identify potential issues and contingency plans with a focus on quality and risk mitigation across our delivery platform projects
Contribute to defining technologies that would benefit the organizations short- and long-term goals
Drive effective communication, escalation, and shared learning with the necessary technical experts and leaders
Collaborate and drive external partners to deliver on portfolio projects
Apply innovation and lessons learned in real time. Enable a culture of continuous improvement to drive efficiency through process improvement, technology and automation, and shared learning

Skills

Nanomedicine

Targeted Delivery

Drug Delivery Systems

Injection Devices

Modeling and Simulation

Injection Physiology

Connected Devices

Digital Biomarkers

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free